ADAR1 Capital Management, LLC - Aug 9, 2024 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PIRS)

Role
10%+ Owner
Signature
ADAR1 Capital Management, LLC, By /s/ Daniel Schneeberger, Manager
Stock symbol
PIRS
Transactions as of
Aug 9, 2024
Transactions value $
$92,326
Form type
4
Date filed
8/12/2024, 06:48 PM
Previous filing
Jul 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PIRS Common Stock Purchase $44.7K +3K +2.41% $14.89 127K Aug 9, 2024 By: ADAR1 Partners F1, F3
transaction PIRS Common Stock Purchase $35.6K +2.24K +1.76% $15.88 130K Aug 12, 2024 By: ADAR1 Partners F1, F3
transaction PIRS Common Stock Purchase $12K +757 +5.29% $15.88 15.1K Aug 12, 2024 By: Spearhead Insurance Solutions IDF, LLC - Series ADAR1 F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by ADAR1 Partners, LP ("ADAR1 Partners"). Because of the relationship between ADAR1 Partners and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by ADAR1 Partners.
F2 ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by Spearhead Insurance Solutions IDF, LLC - Series ADAR1 ("Spearhead"). Because of the relationship between Spearhead and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by Spearhead.
F3 For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.